You are here

  • Home
  • Archive
  • Volume 77, Issue 4
  • Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
l’Ami MJ, Krieckaert CL, Nurmohamed MT, et al
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Annals of the Rheumatic Diseases 2018;77:484-487.